International
High Tide Launches Europe’s First Canna Cabana Store in Berlin
BERLIN – High Tide Inc., the Calgary-based Cannabis retailer known ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
ANTG Inks Deal with Curaleaf to Supply Medical Cannabis for UK Patients
LONDON – Australian Natural Therapeutics Group, a leading cultivator of pharmaceutical-grade Cannabis, has reached an agreement with Curaleaf Laboratories to bring its products to British patients, marking a cross-continental push into Europe's second-largest medical Cannabis ...
Bioxyne Reports Record Revenue, Yet Cash Outflows Climb on Expansion Push
SYDNEY – Bioxyne Limited, an Australian life sciences and wellness products company, posted its highest quarterly revenue on record for the period ended September 30, with sales reaching A$14.1 million, a 210% jump from the ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
Australian Cannabis Prices Drop to New Lows, Pressuring Domestic Producers
MELBOURNE – Medicinal Cannabis flower prices in Australia have fallen to a minimum of $3.30 per gram at the patient level, a development that has intensified debates over the viability of the country's homegrown industry. ...
SynBiotic Builds North American Ties to Secure Overseas Funding
DÜSSELDORF – SynBiotic SE, a publicly traded European company focused on medical Сannabis and industrial hemp, has formed alliances with several North American advisory firms to broaden its reach among global investors. The move aims ...
German Health Ministry Draft Sparks Patient Backlash Over Medical Cannabis Access
FRANKFURT – A recent survey by MedCanOneStop, a German medical Cannabis platform, has highlighted sharp concerns among patients about a proposed amendment from the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG) that would limit ...
High Tide Enters German Medical Cannabis Market with Remexian Majority Stake Acquisition
CALGARY – High Tide Inc., a leading Canadian Cannabis retailer, announced its strategic entry into Germany’s medical Cannabis market through a 51% acquisition of Remexian Pharma GmbH, a Frankfurt-based pharmaceutical wholesaler. The deal, valued at ...
Germany’s Medical Cannabis Imports Hit Record in Q2 2025, Sparking Debate Over Misuse
BERLIN – Germany’s medical Cannabis market continues to set records, with imports reaching 43.3 tons in the second quarter of 2025, according to data from the Federal Institute for Drugs and Medical Devices (BfArM). This ...
Aurora Launches Whistler Brand in Australia
EDMONTON – Aurora Cannabis Inc. announced the introduction of its Whistler Cannabis Co. brand to the Australian market, marking a significant step in its international expansion strategy. The launch brings two high-potency cultivars, Ginger Breath ...
Canopy Growth Expands its Presence in Australia
OTTAWA – Canopy Growth Corporation has introduced its Canadian-grown 7ACRES brand to the Australian medical Cannabis market, marking a strategic expansion of its global medical portfolio. The launch, announced on August 5, features two high-THC ...
Canada’s Cannabis Industry Defies Economic Odds
TORONTO – In a striking contrast to Canada’s faltering economy, the legal Cannabis industry continues to flourish, bolstering the nation’s GDP while other sectors struggle. Statistics Canada reports that the licensed cannabis sector grew by ...
Aurora Cannabis Inc. Reports 93% Sales Surge & Focus on Medical Market Dominance
OTTAWA – Aurora Cannabis Inc. (ACB), a leading Canadian cannabis producer, has reported a 93% jump in sales for its latest quarter, cementing its position in the medical cannabis market. The Edmonton-based company’s financial results, ...
HYTN Secures Health Canada Drug Licence to Propel Cannabinoid Prescription Drug Pathway
LOS ANGELES- Vancouver-based HYTN Innovations Inc. (CSE: HYTN; OTC Pink: HYTNF) announced on July 14, 2025, that it has been granted a Cannabis Drug Licence (CDL) by Health Canada, effective July 2. This licence enhances HYTN’s existing Drug Establishment Licence ...
Brazilian App Turns Patient Adoption Into a Cannabis Data Asset
LOS ANGELES- Brazil’s health-tech startup Blis says its mobile platform now supports more than 300,000 registered patients, generates roughly R$2 million (about US$363,000) in monthly revenue and reaches users in more than 1,800 municipalities. By ...
Curaleaf Takes Full Control of European Arm in Bold Strategic Move
LOS ANGELES - In a major development out of the cannabis industry, Curaleaf Holdings, Inc. (TSX: CURA, OTCQX: CURLF) has just announced it’s taken full ownership of Curaleaf International, buying out its minority partner’s stake ...
